%PDF-1.6
%
1 0 obj
<>
endobj
2 0 obj
<>stream
Mikyung Kelly Seo, John Cairns
Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer
www.plosone.org
www.plosone.org
endstream
endobj
3 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 10 0 R/Contents 11 0 R/TrimBox[0 0 612 792]>>
endobj
10 0 obj
[12 0 R 13 0 R 14 0 R 15 0 R 16 0 R 17 0 R 18 0 R 19 0 R 20 0 R 21 0 R 22 0 R 23 0 R 24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R]
endobj
12 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref001)>>
endobj
13 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref002)>>
endobj
14 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref002)>>
endobj
15 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref003)>>
endobj
16 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref004)>>
endobj
17 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref005)>>
endobj
18 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref006)>>
endobj
19 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref007)>>
endobj
20 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref008)>>
endobj
21 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref009)>>
endobj
22 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref011)>>
endobj
23 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref012)>>
endobj
24 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref013)>>
endobj
25 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref014)>>
endobj
26 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref015)>>
endobj
27 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref016)>>
endobj
28 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref017)>>
endobj
29 0 obj
<>/Border[0 0 0]/A 30 0 R>>
endobj
30 0 obj
<>
endobj
11 0 obj
[31 0 R 32 0 R 33 0 R 34 0 R 35 0 R 36 0 R 37 0 R 38 0 R 39 0 R 40 0 R 41 0 R 42 0 R 43 0 R 44 0 R 45 0 R 46 0 R 47 0 R 48 0 R]
endobj
31 0 obj
<>stream
q
0.45 0.36 0.35 0.01 k
0 w
575.9997 591.91 m
199.9998 591.91 l
199.9998 592.41 l
575.9997 592.41 l
f*
0.83 0.64 0.02 0 k
290.2677 497.9339 m
295.0299 497.9339 l
h
f*
509.7827 484.8945 m
514.5449 484.8945 l
h
f*
369.2409 471.9118 m
374.0031 471.9118 l
h
f*
432.6803 458.9291 m
437.4425 458.9291 l
h
f*
225.978 367.937 m
230.7402 367.937 l
h
f*
235.2189 367.937 m
239.9811 367.937 l
h
f*
376.5543 354.8976 m
381.3165 354.8976 l
h
f*
215.4898 341.915 m
220.252 341.915 l
h
f*
224.674 341.915 m
229.4362 341.915 l
h
f*
444.9827 315.9496 m
449.7449 315.9496 l
h
f*
454.9039 315.9496 m
464.4283 315.9496 l
h
f*
244.2898 263.9055 m
253.8142 263.9055 l
h
f*
242.7024 185.8961 m
252.2268 185.8961 l
h
f*
256.7055 185.8961 m
266.1732 185.8961 l
h
f*
268.3843 146.948 m
277.9087 146.948 l
h
f*
282.3307 146.948 m
291.8551 146.948 l
h
f*
234.1984 133.9087 m
243.6661 133.9087 l
h
f*
0 g
1 j
1 J
11.4998 0 0 11.4998 200.0125 706.3937 cm
BT
/F2 1 Tf
1 TL
-0.0035 Tc
0 0 Td
(Conclusion)Tj
ET
Q
q
1 j
1 J
0 w
9.5 0 0 9.5 200.0125 689.3858 cm
BT
/F0 1 Tf
1 TL
-0.0042 Tc
0 0 Td
(Cancer)Tj
3.4075 0 Td
(biomarkers)Tj
5.1143 0 Td
(for)Tj
1.3725 0 Td
(targeted)Tj
3.8492 0 Td
(therapies)Tj
4.2847 0 Td
(in)Tj
0.9787 0 Td
(mCRC)Tj
3.1987 0 Td
(were)Tj
2.3632 0 Td
(mostly)Tj
3.0853 0 Td
(found)Tj
2.6914 0 Td
(to)Tj
1.0443 0 Td
(be)Tj
1.3189 0 Td
(cost-effective;)Tj
-32.7087 -1.474 Td
(otherwise,)Tj
4.7263 0 Td
(they)Tj
2.0887 0 Td
(at)Tj
1.0503 0 Td
(least)Tj
2.3035 0 Td
(improved)Tj
4.2848 0 Td
(the)Tj
1.5993 0 Td
(cost-effectiveness)Tj
8.1459 0 Td
(of)Tj
1.0443 0 Td
(targeted)Tj
3.8492 0 Td
(therapies)Tj
4.2788 0 Td
(by)Tj
1.2651 0 Td
(saving)Tj
-34.6362 -1.468 Td
(some)Tj
2.6436 0 Td
(costs.)Tj
2.8108 0 Td
(However,)Tj
4.4041 0 Td
(this)Tj
1.7545 0 Td
(did)Tj
1.5337 0 Td
(not)Tj
1.5934 0 Td
(necessarily)Tj
5.162 0 Td
(make)Tj
2.6437 0 Td
(their)Tj
2.1423 0 Td
(corresponding)Tj
6.4749 0 Td
(therapies)Tj
4.2848 0 Td
(cost-)Tj
-35.4478 -1.474 Td
(effective.)Tj
4.1833 0 Td
(While)Tj
2.6914 0 Td
(companion)Tj
5.0546 0 Td
(biomarkers)Tj
5.1143 0 Td
(reduced)Tj
3.7894 0 Td
(therapy)Tj
3.515 0 Td
(costs,)Tj
2.8167 0 Td
(the)Tj
1.5934 0 Td
(savings)Tj
3.5686 0 Td
(were)Tj
2.3632 0 Td
(not)Tj
1.5994 0 Td
(suffi-)Tj
-36.2893 -1.474 Td
(cient)Tj
2.3035 0 Td
(to)Tj
1.0503 0 Td
(make)Tj
2.6436 0 Td
(the)Tj
1.5934 0 Td
(corresponding)Tj
6.4749 0 Td
(agents)Tj
3.1927 0 Td
(cost-effective.)Tj
6.3317 0 Td
(Evaluation)Tj
4.8278 0 Td
(of)Tj
1.0503 0 Td
(biomarkers)Tj
5.1083 0 Td
(was)Tj
1.9813 0 Td
(often)Tj
-36.5578 -1.474 Td
(restricted)Tj
4.2847 0 Td
(to)Tj
1.0503 0 Td
(the)Tj
1.5934 0 Td
(cost)Tj
2.0409 0 Td
(of)Tj
1.0444 0 Td
(tests)Tj
2.3154 0 Td
(and)Tj
1.8679 0 Td
(did)Tj
1.5337 0 Td
(not)Tj
1.5934 0 Td
(consider)Tj
3.9505 0 Td
(their)Tj
2.1424 0 Td
(clinical)Tj
3.1689 0 Td
(values)Tj
3.0733 0 Td
(or)Tj
1.098 0 Td
(biomarker)Tj
-30.7572 -1.474 Td
(prevalence.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 529.0015 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Introduction)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 511.9937 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(Colorectal)Tj
4.3369 0 Td
(cancer)Tj
2.846 0 Td
(\(CRC\))Tj
2.846 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4683 0 Td
(third)Tj
2.2167 0 Td
(most)Tj
2.2053 0 Td
(common)Tj
3.8438 0 Td
(cancer)Tj
2.8459 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(third)Tj
2.211 0 Td
(leading)Tj
3.1351 0 Td
(cause)Tj
2.3868 0 Td
(of)Tj
1.0148 0 Td
(can-)Tj
-35.4045 -1.2982 Td
(cer)Tj
1.4343 0 Td
(deaths)Tj
2.7949 0 Td
(worldwide)Tj
4.4617 0 Td
([)Tj
0.83 0.64 0.02 0 k
(1)Tj
0 g
(].)Tj
1.5987 0 Td
(In)Tj
1.1056 0 Td
(Europe,)Tj
3.3618 0 Td
(it)Tj
0.788 0 Td
(is)Tj
0.8504 0 Td
(the)Tj
1.4684 0 Td
(most)Tj
2.2053 0 Td
(common)Tj
3.8438 0 Td
(cause)Tj
2.3924 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8403 0 Td
(death)Tj
2.4321 0 Td
(after)Tj
2.0353 0 Td
(lung)Tj
-34.6278 -1.3039 Td
(cancer.)Tj
3.067 0 Td
(In)Tj
1.1112 0 Td
(2012,)Tj
2.3471 0 Td
(241,600)Tj
3.2995 0 Td
(men)Tj
2.0126 0 Td
(and)Tj
1.7291 0 Td
(205,200)Tj
3.2995 0 Td
(women)Tj
3.2031 0 Td
(were)Tj
2.1203 0 Td
(diagnosed)Tj
4.2803 0 Td
(with)Tj
2.0013 0 Td
(CRC)Tj
2.1656 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(],)Tj
1.6044 0 Td
(and)Tj
1.7291 0 Td
(113,200)Tj
-33.9701 -1.2983 Td
(men)Tj
2.0125 0 Td
(and)Tj
1.7292 0 Td
(101,500)Tj
3.2995 0 Td
(women)Tj
3.2031 0 Td
(died)Tj
1.9672 0 Td
(from)Tj
2.2054 0 Td
(CRC)Tj
2.1656 0 Td
([)Tj
0.83 0.64 0.02 0 k
(2)Tj
0 g
(].)Tj
1.5988 0 Td
(In)Tj
1.1111 0 Td
(the)Tj
1.4684 0 Td
(USA,)Tj
2.3414 0 Td
(136,830)Tj
3.2995 0 Td
(cases)Tj
2.2223 0 Td
(newly)Tj
2.5795 0 Td
(diagnosed)Tj
4.2803 0 Td
(with)Tj
-35.4838 -1.2983 Td
(CRC)Tj
2.1656 0 Td
(and)Tj
1.7291 0 Td
(50,310)Tj
2.8233 0 Td
(deaths)Tj
2.795 0 Td
(with)Tj
1.9955 0 Td
(CRC)Tj
2.1714 0 Td
(were)Tj
2.1203 0 Td
(projected)Tj
3.9684 0 Td
(in)Tj
1.0375 0 Td
(2014)Tj
2.1203 0 Td
([)Tj
0.83 0.64 0.02 0 k
(3)Tj
0 g
(].)Tj
-21.7302 -1.2982 Td
(Despite)Tj
3.2484 0 Td
(recent)Tj
2.71 0 Td
(developments)Tj
5.7713 0 Td
(in)Tj
1.0374 0 Td
(targeted)Tj
3.4583 0 Td
(therapies,)Tj
4.0705 0 Td
(gene)Tj
2.0806 0 Td
(sequencing)Tj
4.7168 0 Td
(and)Tj
1.7292 0 Td
(molecular)Tj
4.2179 0 Td
(diag-)Tj
-34.2366 -1.3039 Td
(nostics,)Tj
3.2087 0 Td
(promising)Tj
4.3484 0 Td
(optimized)Tj
4.2576 0 Td
(and)Tj
1.7291 0 Td
(personalized)Tj
5.2611 0 Td
(treatment)Tj
4.1385 0 Td
(regimens)Tj
3.9005 0 Td
(tailored)Tj
3.2938 0 Td
(for)Tj
1.3833 0 Td
(individual)Tj
-31.521 -1.2983 Td
(patients,)Tj
3.5943 0 Td
(CRC)Tj
2.1656 0 Td
(remains)Tj
3.4469 0 Td
(one)Tj
1.6951 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.474 0 Td
(less)Tj
1.6101 0 Td
(treatable)Tj
3.6567 0 Td
(cancers.)Tj
3.4299 0 Td
(Most)Tj
2.279 0 Td
(cases)Tj
2.2224 0 Td
(of)Tj
1.0148 0 Td
(CRC)Tj
2.1656 0 Td
(are)Tj
1.4513 0 Td
(sporadic)Tj
3.6284 0 Td
(and)Tj
-34.8489 -1.2983 Td
(develop)Tj
3.3165 0 Td
(slowly)Tj
2.7212 0 Td
(over)Tj
1.9786 0 Td
(several)Tj
2.931 0 Td
(years,)Tj
2.4888 0 Td
(progressing)Tj
4.8812 0 Td
(through)Tj
3.4469 0 Td
(a)Tj
0.652 0 Td
(series)Tj
2.4264 0 Td
(of)Tj
1.0148 0 Td
(clinical)Tj
3.0784 0 Td
(and)Tj
1.7292 0 Td
(histopathological)Tj
-30.665 -1.3039 Td
(stages)Tj
2.5625 0 Td
(from)Tj
2.2053 0 Td
(single)Tj
2.5285 0 Td
(crypt)Tj
2.2904 0 Td
(lesions)Tj
2.931 0 Td
(through)Tj
3.4469 0 Td
(benign)Tj
2.9763 0 Td
(adenomas)Tj
4.2803 0 Td
(to)Tj
1.0205 0 Td
(malignant)Tj
4.2859 0 Td
(carcinomas,)Tj
5.0343 0 Td
(as)Tj
1.0148 0 Td
(a)Tj
0.652 0 Td
(result)Tj
-35.2287 -1.2983 Td
(of)Tj
1.0147 0 Td
(an)Tj
1.2019 0 Td
(accumulation)Tj
5.675 0 Td
(of)Tj
1.0148 0 Td
(mutations)Tj
4.2859 0 Td
(in)Tj
1.0318 0 Td
(tumor)Tj
2.7439 0 Td
(suppressor)Tj
4.5411 0 Td
(genes)Tj
2.4378 0 Td
(and)Tj
1.7348 0 Td
(oncogenes)Tj
4.4277 0 Td
(or)Tj
1.0941 0 Td
(a)Tj
0.6577 0 Td
(genetic)Tj
3.067 0 Td
(insta-)Tj
-34.9282 -1.2982 Td
(bility)Tj
2.2563 0 Td
([)Tj
0.83 0.64 0.02 0 k
(4)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2643 0 Td
(5)Tj
0 g
(].)Tj
1.2585 0 Td
(The)Tj
1.7858 0 Td
(5-year)Tj
2.727 0 Td
(survival)Tj
3.3392 0 Td
(rate)Tj
1.7461 0 Td
(for)Tj
1.3889 0 Td
(early-stage)Tj
4.4788 0 Td
(CRC)Tj
2.1713 0 Td
(is)Tj
0.8447 0 Td
(about)Tj
2.4945 0 Td
(90%)Tj
1.9275 0 Td
(but)Tj
1.5534 0 Td
(it)Tj
0.788 0 Td
(falls)Tj
1.7915 0 Td
(to)Tj
1.0261 0 Td
(10%)Tj
1.9276 0 Td
(for)Tj
-34.7695 -1.3039 Td
(late-stage)Tj
3.9514 0 Td
(CRC)Tj
2.1713 0 Td
(metastasized)Tj
5.2781 0 Td
(to)Tj
1.0262 0 Td
(distant)Tj
2.9536 0 Td
(sites)Tj
1.9333 0 Td
([)Tj
0.83 0.64 0.02 0 k
(6)Tj
0 g
(])Tj
1.3776 0 Td
(and)Tj
1.7291 0 Td
(cancer)Tj
2.846 0 Td
(mortality)Tj
3.9118 0 Td
(is)Tj
0.8503 0 Td
(mainly)Tj
2.9877 0 Td
(due)Tj
1.7008 0 Td
(to)Tj
1.0262 0 Td
(metasta-)Tj
-33.7434 -1.2983 Td
(sis)Tj
1.2075 0 Td
([)Tj
0.83 0.64 0.02 0 k
(7)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.2586 0 Td
(8)Tj
0 g
(].)Tj
-1.2699 -1.2983 Td
(There)Tj
2.5795 0 Td
(are)Tj
1.4513 0 Td
(multiple)Tj
3.566 0 Td
(treatments)Tj
4.4957 0 Td
(available)Tj
3.668 0 Td
(for)Tj
1.3833 0 Td
(patients)Tj
3.3675 0 Td
(with)Tj
1.9956 0 Td
(metastatic)Tj
4.2803 0 Td
(colorectal)Tj
4.0989 0 Td
(cancer)Tj
-32.0823 -1.2982 Td
(\(mCRC\),)Tj
3.8947 0 Td
(including)Tj
4.0365 0 Td
(targeted)Tj
3.464 0 Td
(therapies)Tj
3.8437 0 Td
(guided)Tj
2.9594 0 Td
(by)Tj
1.1792 0 Td
(biomarkers)Tj
4.7791 0 Td
([)Tj
0.83 0.64 0.02 0 k
(9)Tj
0 g
()Tj
0.83 0.64 0.02 0 k
(11)Tj
0 g
(].)Tj
3.0728 0 Td
(Recent)Tj
2.9593 0 Td
(advances)Tj
3.8268 0 Td
(in)Tj
1.0318 0 Td
(tar-)Tj
-35.0473 -1.3039 Td
(geted)Tj
2.3584 0 Td
(therapies)Tj
3.8437 0 Td
(have)Tj
2.058 0 Td
(raised)Tj
2.6078 0 Td
(expectations)Tj
5.1817 0 Td
(that)Tj
1.7802 0 Td
(clinical)Tj
3.0784 0 Td
(application)Tj
4.6771 0 Td
(of)Tj
1.0148 0 Td
(biomarkers)Tj
4.7792 0 Td
(might)Tj
2.5965 0 Td
(improve)Tj
-33.9758 -1.2983 Td
(health)Tj
2.6758 0 Td
(benefits)Tj
3.3392 0 Td
(while)Tj
2.3641 0 Td
(avoiding)Tj
3.6964 0 Td
(unnecessary)Tj
5.0966 0 Td
(toxicity)Tj
3.1975 0 Td
(and)Tj
1.7348 0 Td
(adverse)Tj
3.2144 0 Td
(events.)Tj
2.9537 0 Td
(It)Tj
0.8561 0 Td
(can)Tj
1.6271 0 Td
(potentially)Tj
-30.7557 -1.2983 Td
(reduce)Tj
2.9139 0 Td
(health)Tj
2.6816 0 Td
(care)Tj
1.8709 0 Td
(system)Tj
2.9366 0 Td
(costs)Tj
2.1714 0 Td
(by)Tj
1.1792 0 Td
(containing)Tj
4.5297 0 Td
(unnecessary)Tj
5.0967 0 Td
(costs)Tj
2.1713 0 Td
(without)Tj
3.3335 0 Td
(hurting)Tj
3.2258 0 Td
(patient)Tj
3.0047 0 Td
(health)Tj
-35.1153 -1.3039 Td
(outcomes)Tj
4.0875 0 Td
([)Tj
0.83 0.64 0.02 0 k
(12)Tj
0 g
(].)Tj
-2.8913 -1.2983 Td
(These)Tj
2.5681 0 Td
(therapies)Tj
3.8438 0 Td
(comprise)Tj
3.9118 0 Td
(epidermal)Tj
4.2519 0 Td
(growth)Tj
3.0728 0 Td
(factor)Tj
2.5398 0 Td
(receptor)Tj
3.5546 0 Td
(\(EGFR\),)Tj
3.5603 0 Td
(vascular)Tj
3.4753 0 Td
(endothelial)Tj
-31.9746 -1.2982 Td
(growth)Tj
3.0727 0 Td
(factor)Tj
2.5398 0 Td
(\(VEGF\),)Tj
3.634 0 Td
(and)Tj
1.7291 0 Td
(tyrosine)Tj
3.4526 0 Td
(kinase)Tj
2.7496 0 Td
(\(TK\))Tj
2.1883 0 Td
(inhibitors.)Tj
4.3654 0 Td
(VEGF-targeted)Tj
6.3212 0 Td
(therapies)Tj
3.8437 0 Td
(include)Tj
-33.8964 -1.3039 Td
(bevacizumab,)Tj
5.6522 0 Td
(aflibercept,)Tj
4.6488 0 Td
(and)Tj
1.7291 0 Td
(ramucirumab.)Tj
5.9471 0 Td
(EGFR)Tj
2.6532 0 Td
(inhibitors)Tj
4.1442 0 Td
(are)Tj
1.4513 0 Td
(cetuximab)Tj
4.3824 0 Td
(and)Tj
1.7291 0 Td
(panitumu-)Tj
-32.3374 -1.2983 Td
(mab.)Tj
2.2053 0 Td
(Regorafenib)Tj
5.074 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.6519 0 Td
(TK)Tj
1.508 0 Td
(inhibitor.)Tj
4.0025 0 Td
(Of)Tj
1.2586 0 Td
(these,)Tj
2.4775 0 Td
(only)Tj
1.9786 0 Td
(anti-EGFR)Tj
4.5524 0 Td
(therapies)Tj
3.8437 0 Td
(have)Tj
2.058 0 Td
(a)Tj
0.6519 0 Td
(predictive)Tj
4.1953 0 Td
(bio-)Tj
-35.3081 -1.2983 Td
(marker)Tj
3.135 0 Td
(clearly)Tj
2.8177 0 Td
(established)Tj
4.5977 0 Td
(for)Tj
1.389 0 Td
(guiding)Tj
3.2882 0 Td
(treatment)Tj
4.1329 0 Td
(options)Tj
3.2258 0 Td
(as)Tj
1.0148 0 Td
(an)Tj
1.2018 0 Td
(integral)Tj
3.2769 0 Td
(part)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4683 0 Td
(clinical)Tj
-32.4054 -1.3039 Td
(pathways)Tj
3.9287 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7405 0 Td
(14)Tj
0 g
(].)Tj
1.7348 0 Td
(Current)Tj
3.4242 0 Td
(guidelines)Tj
4.2746 0 Td
(in)Tj
1.0375 0 Td
(Europe)Tj
3.1351 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.474 0 Td
(USA)Tj
2.1147 0 Td
(recommend)Tj
5.0853 0 Td
(that)Tj
1.7801 0 Td
(all)Tj
1.1452 0 Td
(mCRC)Tj
-32.6038 -1.2983 Td
(patients)Tj
3.3675 0 Td
(receive)Tj
3.0047 0 Td
(Kirsten)Tj
3.1634 0 Td
(rat)Tj
1.3266 0 Td
(sarcoma)Tj
3.5717 0 Td
(\(KRAS\))Tj
3.3505 0 Td
(testing)Tj
2.8857 0 Td
(prior)Tj
2.2507 0 Td
(to)Tj
1.0261 0 Td
(treatment)Tj
4.1385 0 Td
(with)Tj
1.9956 0 Td
(EGFR)Tj
2.6532 0 Td
(inhibitors)Tj
-32.7342 -1.2982 Td
(since)Tj
2.245 0 Td
(KRAS)Tj
2.6702 0 Td
(mutation)Tj
3.9231 0 Td
(statuswild)Tj
4.7452 0 Td
(type)Tj
1.9105 0 Td
(\(WT\))Tj
2.4775 0 Td
(or)Tj
1.0998 0 Td
(mutant)Tj
3.1465 0 Td
(\(MT\)predicts)Tj
6.1114 0 Td
(the)Tj
1.4684 0 Td
(response)Tj
3.7303 0 Td
(to)Tj
1.0262 0 Td
(anti-)Tj
-34.5541 -1.2983 Td
(EFGR)Tj
2.6532 0 Td
(therapies)Tj
3.8437 0 Td
([)Tj
0.83 0.64 0.02 0 k
(15)Tj
0 g
(,)Tj
0.83 0.64 0.02 0 k
1.7348 0 Td
(16)Tj
0 g
(].)Tj
1.7405 0 Td
(Recently,)Tj
3.8834 0 Td
(the)Tj
1.4683 0 Td
(testing)Tj
2.8857 0 Td
(was)Tj
1.6951 0 Td
(expanded)Tj
4.0875 0 Td
(to)Tj
1.0262 0 Td
(RAS)Tj
2.0012 0 Td
(testing)Tj
2.88 0 Td
(\(both)Tj
2.4038 0 Td
(KRAS)Tj
2.6759 0 Td
(and)Tj
-34.9793 -1.3039 Td
(NRAS\))Tj
3.0784 0 Td
([)Tj
0.83 0.64 0.02 0 k
(17)Tj
0 g
(].)Tj
2.0749 0 Td
(KRAS)Tj
2.6759 0 Td
(and)Tj
1.7291 0 Td
(NRAS)Tj
2.7383 0 Td
(mutations)Tj
4.2803 0 Td
(serve)Tj
2.2563 0 Td
(as)Tj
1.0148 0 Td
(predictive)Tj
4.1953 0 Td
(biomarkers)Tj
4.7735 0 Td
(for)Tj
1.3889 0 Td
(anti-EGFR)Tj
4.5525 0 Td
(thera-)Tj
-34.7582 -1.2983 Td
(pies,)Tj
2.0125 0 Td
(only)Tj
1.9729 0 Td
(patients)Tj
3.3676 0 Td
(with)Tj
1.9956 0 Td
(RAS)Tj
2.0012 0 Td
(wild-type)Tj
3.9855 0 Td
(tumors)Tj
3.1067 0 Td
(benefit)Tj
2.9707 0 Td
(from)Tj
2.2054 0 Td
(these)Tj
2.2507 0 Td
(therapies.)Tj
4.0705 0 Td
(No)Tj
1.4627 0 Td
(positive)Tj
3.3108 0 Td
(predic-)Tj
-34.7128 -1.2982 Td
(tive)Tj
1.661 0 Td
(biomarkers)Tj
4.7792 0 Td
(exist)Tj
2.0353 0 Td
(yet,)Tj
1.6214 0 Td
(that)Tj
1.7801 0 Td
(identify)Tj
3.2939 0 Td
(eligible)Tj
3.067 0 Td
(patients)Tj
3.3676 0 Td
(rather)Tj
2.6475 0 Td
(than)Tj
2.0296 0 Td
(exclude)Tj
3.2542 0 Td
(ineligible)Tj
3.8834 0 Td
(patients.)Tj
-33.4202 -1.3039 Td
(No)Tj
1.4626 0 Td
(other)Tj
2.3471 0 Td
(molecular)Tj
4.2179 0 Td
(marker)Tj
3.1351 0 Td
(is)Tj
0.8504 0 Td
(part)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(routine)Tj
3.1635 0 Td
(clinical)Tj
3.0727 0 Td
(practice)Tj
3.3789 0 Td
(when)Tj
2.4037 0 Td
(deciding)Tj
3.6737 0 Td
(optimized)Tj
4.2576 0 Td
(and)Tj
-34.8205 -1.2983 Td
(tailored)Tj
3.2938 0 Td
(treatment)Tj
4.1329 0 Td
(regimens)Tj
3.9004 0 Td
(for)Tj
1.389 0 Td
(mCRC)Tj
2.9877 0 Td
(patients.)Tj
3.5943 0 Td
(However,)Tj
4.0762 0 Td
(irinotecan)Tj
4.3086 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(biomarker-directed)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I1 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 311.3574 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Do)Tj
1.474 0 Td
(cancer)Tj
3.1748 0 Td
(biomarke)Tj
4.0394 0 Td
(rs)Tj
1.0417 0 Td
(make)Tj
2.6292 0 Td
(targeted)Tj
3.8268 0 Td
(therap)Tj
2.778 0 Td
(ies)Tj
1.474 0 Td
(cost-effect)Tj
4.5426 0 Td
(ive?)Tj
2.0197 0 Td
(SLR)Tj
2.1401 0 Td
(in)Tj
0.978 0 Td
(mCRC)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.02044)Tj
4.089 0 Td
(96)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(26,)Tj
1.5874 0 Td
(2018)Tj
32.2798 0 Td
(2)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
32 0 obj
<>stream
endstream
endobj
33 0 obj
<>stream
endstream
endobj
34 0 obj
<>stream
endstream
endobj
35 0 obj
<>stream
endstream
endobj
36 0 obj
<>stream
endstream
endobj
37 0 obj
<>stream
endstream
endobj
38 0 obj
<>stream
endstream
endobj
39 0 obj
<>stream
endstream
endobj
40 0 obj
<>stream
endstream
endobj
41 0 obj
<>stream
endstream
endobj
42 0 obj
<>stream
endstream
endobj
43 0 obj
<>stream
endstream
endobj
44 0 obj
<>stream
endstream
endobj
45 0 obj
<>stream
endstream
endobj
46 0 obj
<>stream
endstream
endobj
47 0 obj
<>stream
endstream
endobj
48 0 obj
<>stream
BT
66.402 0 Td
(23)Tj
ET
Q
endstream
endobj
49 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 51 0 R/Contents 52 0 R/TrimBox[0 0 612 792]>>
endobj
51 0 obj
[53 0 R 54 0 R 55 0 R 56 0 R 57 0 R 58 0 R 59 0 R 60 0 R]
endobj
53 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref018)>>
endobj
54 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref019)>>
endobj
55 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref019)>>
endobj
56 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref020)>>
endobj
57 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.s002)>>
endobj
58 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.ref013)>>
endobj
59 0 obj
<>/Border[0 0 0]/Dest(Rpone.0204496.s003)>>
endobj
60 0 obj
<>/Border[0 0 0]/A 61 0 R>>
endobj
61 0 obj
<>
endobj
52 0 obj
[62 0 R 63 0 R 64 0 R 65 0 R 66 0 R 67 0 R 68 0 R 69 0 R 70 0 R 71 0 R]
endobj
62 0 obj
<>stream
q
0.83 0.64 0.02 0 k
333.0142 680.315 m
342.5386 680.315 l
h
f*
452.5228 628.3276 m
462.0472 628.3276 l
h
f*
529.0583 576.3402 m
538.5827 576.3402 l
h
f*
266.9669 524.2961 m
276.4913 524.2961 l
h
f*
228.3591 326.6079 m
262.2614 326.6079 l
h
f*
479.1685 222.6331 m
488.6929 222.6331 l
h
f*
531.4961 146.948 m
565.3984 146.948 l
h
f*
0 g
1 j
1 J
0 w
10 0 0 10 200.0125 707.4141 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(chemotherapy)Tj
5.947 0 Td
(for)Tj
1.389 0 Td
(treating)Tj
3.3222 0 Td
(mCRC,)Tj
3.2144 0 Td
(which)Tj
2.6532 0 Td
(unlike)Tj
2.7269 0 Td
(molecularly)Tj
4.921 0 Td
(targeted)Tj
3.4639 0 Td
(therapies,)Tj
4.0648 0 Td
(is)Tj
0.8504 0 Td
(a)Tj
0.652 0 Td
(cytotoxic)Tj
-33.2048 -1.3039 Td
(drug)Tj
2.1089 0 Td
(given)Tj
2.3811 0 Td
(to)Tj
1.0261 0 Td
(get)Tj
1.406 0 Td
(rid)Tj
1.389 0 Td
(of)Tj
1.0148 0 Td
(or)Tj
1.0941 0 Td
(control)Tj
3.1238 0 Td
(cancer)Tj
2.846 0 Td
(cells.)Tj
2.1429 0 Td
(UGT1A1)Tj
3.9175 0 Td
(testing)Tj
2.8857 0 Td
(showed)Tj
3.2484 0 Td
(clinical)Tj
3.0784 0 Td
(benefits)Tj
3.3336 0 Td
(for)Tj
-34.9963 -1.2982 Td
(the)Tj
1.4683 0 Td
(administration)Tj
6.1681 0 Td
(of)Tj
1.0148 0 Td
(irinotecan)Tj
4.3087 0 Td
([)Tj
0.83 0.64 0.02 0 k
(18)Tj
0 g
(].)Tj
2.0806 0 Td
(All)Tj
1.3946 0 Td
(these)Tj
2.2564 0 Td
(predictive)Tj
4.1896 0 Td
(biomarkers)Tj
4.7791 0 Td
(are)Tj
1.4514 0 Td
(currently)Tj
3.8834 0 Td
(used)Tj
2.058 0 Td
(in)Tj
-35.053 -1.2983 Td
(clinical)Tj
3.0727 0 Td
(settings)Tj
3.2428 0 Td
(to)Tj
1.0261 0 Td
(make)Tj
2.3925 0 Td
(treatment)Tj
4.1385 0 Td
(decisions)Tj
3.9061 0 Td
(for)Tj
1.3833 0 Td
(the)Tj
1.474 0 Td
(safe)Tj
1.7235 0 Td
(and)Tj
1.7291 0 Td
(effective)Tj
3.515 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(targeted)Tj
3.4582 0 Td
(therapies)Tj
-33.6073 -1.2983 Td
(in)Tj
1.0318 0 Td
(treating)Tj
3.3278 0 Td
(mCRC.)Tj
-3.1634 -1.3039 Td
(Third-party)Tj
4.9549 0 Td
(payers)Tj
2.7779 0 Td
(often)Tj
2.2904 0 Td
(prioritize)Tj
3.9231 0 Td
(competing)Tj
4.4901 0 Td
(interventions)Tj
5.5332 0 Td
(by)Tj
1.1849 0 Td
(assessing)Tj
3.7984 0 Td
(cost-effectivene)Tj
6.2078 0 Td
(ss)Tj
-36.3569 -1.2982 Td
(using)Tj
2.3867 0 Td
(cost-effectiveness)Tj
7.1433 0 Td
(\(CEA\))Tj
2.8176 0 Td
(and)Tj
1.7348 0 Td
(cost-utility)Tj
4.5184 0 Td
(analysis)Tj
3.3278 0 Td
(\(CUA\))Tj
2.9821 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
1.7858 0 Td
(former)Tj
2.9991 0 Td
(is)Tj
0.8447 0 Td
(often)Tj
-32.6152 -1.2983 Td
(assessed)Tj
3.4695 0 Td
(per)Tj
1.5364 0 Td
(additional)Tj
4.2746 0 Td
(life-years)Tj
3.8381 0 Td
(gained)Tj
2.8857 0 Td
(\(LYs\),)Tj
2.6588 0 Td
(and)Tj
1.7292 0 Td
(the)Tj
1.4683 0 Td
(latter)Tj
2.296 0 Td
(per)Tj
1.5307 0 Td
(additional)Tj
4.2747 0 Td
(quality-adjusted)Tj
-29.962 -1.3039 Td
(life-year)Tj
3.4752 0 Td
(\(QALY\).)Tj
3.7304 0 Td
(Incremental)Tj
5.0966 0 Td
(differences)Tj
4.5638 0 Td
(in)Tj
1.0375 0 Td
(costs)Tj
2.1713 0 Td
(and)Tj
1.7291 0 Td
(benefits)Tj
3.3392 0 Td
(between)Tj
3.5263 0 Td
(alternative)Tj
4.4163 0 Td
(interven-)Tj
-33.0857 -1.2983 Td
(tions)Tj
2.1996 0 Td
(are)Tj
1.4514 0 Td
(the)Tj
1.4683 0 Td
(main)Tj
2.2904 0 Td
(focus)Tj
2.3244 0 Td
(of)Tj
1.0148 0 Td
(economic)Tj
4.1385 0 Td
(evaluations)Tj
4.7225 0 Td
(and)Tj
1.7348 0 Td
(thus,)Tj
2.16 0 Td
(the)Tj
1.4683 0 Td
(primary)Tj
3.4526 0 Td
(study)Tj
2.3924 0 Td
(outcome)Tj
3.7247 0 Td
(is)Tj
0.8504 0 Td
(usu-)Tj
-35.3931 -1.2983 Td
(ally)Tj
1.5987 0 Td
(to)Tj
1.0261 0 Td
(estimate)Tj
3.5433 0 Td
(the)Tj
1.474 0 Td
(incremental)Tj
5.023 0 Td
(cost-effectiveness)Tj
7.1432 0 Td
(ratio)Tj
2.0977 0 Td
(\(ICER\))Tj
3.0954 0 Td
(per)Tj
1.5307 0 Td
(LYs)Tj
1.7518 0 Td
(or)Tj
1.0998 0 Td
(QALYs)Tj
3.1805 0 Td
([)Tj
0.83 0.64 0.02 0 k
(19)Tj
0 g
(].)Tj
2.0749 0 Td
(The)Tj
-34.6391 -1.3039 Td
(comparison)Tj
4.9776 0 Td
(of)Tj
1.0148 0 Td
(alternative)Tj
4.4163 0 Td
(courses)Tj
3.1975 0 Td
(of)Tj
1.0148 0 Td
(action)Tj
2.6985 0 Td
(for)Tj
1.3833 0 Td
(cancer)Tj
2.846 0 Td
(biomarkers)Tj
4.7792 0 Td
(for)Tj
1.3833 0 Td
(targeted)Tj
3.4639 0 Td
(therapies)Tj
3.8437 0 Td
(can)Tj
1.6271 0 Td
(be)Tj
-36.646 -1.2982 Td
(broadly)Tj
3.2654 0 Td
(categorised)Tj
4.7225 0 Td
(into)Tj
1.8425 0 Td
(two)Tj
1.7065 0 Td
(forms:)Tj
2.7949 0 Td
(`test-treat')Tj
4.218 0 Td
(strategy)Tj
3.3278 0 Td
(\(patients)Tj
3.7077 0 Td
(are)Tj
1.4457 0 Td
(treated)Tj
2.999 0 Td
(with)Tj
1.9956 0 Td
(new)Tj
1.8765 0 Td
(interven-)Tj
-33.9021 -1.2983 Td
(tion)Tj
1.8425 0 Td
(guided)Tj
2.9536 0 Td
(by)Tj
1.1849 0 Td
(biomarker)Tj
4.4164 0 Td
(status\))Tj
2.8403 0 Td
(and)Tj
1.7291 0 Td
(`treat-all')Tj
3.7644 0 Td
(strategy)Tj
3.3278 0 Td
(\(all)Tj
1.4854 0 Td
(patients)Tj
3.3675 0 Td
(are)Tj
1.4513 0 Td
(treated)Tj
2.9934 0 Td
(without)Tj
3.3335 0 Td
(bio-)Tj
-34.6901 -1.3039 Td
(marker)Tj
3.135 0 Td
(testing\))Tj
3.2202 0 Td
([)Tj
0.83 0.64 0.02 0 k
(20)Tj
0 g
(].)Tj
-5.159 -1.2983 Td
(To)Tj
1.3379 0 Td
(sum)Tj
1.9332 0 Td
(up,)Tj
1.491 0 Td
(the)Tj
1.4684 0 Td
(use)Tj
1.5307 0 Td
(of)Tj
1.0148 0 Td
(biomarkers)Tj
4.7792 0 Td
(may)Tj
1.9275 0 Td
(permit)Tj
2.9197 0 Td
(optimising)Tj
4.5354 0 Td
(regimens)Tj
3.9004 0 Td
(without)Tj
3.3279 0 Td
(compromising)Tj
-31.3623 -1.2982 Td
(health)Tj
2.6702 0 Td
(outcomes.)Tj
4.3029 0 Td
(This)Tj
1.9843 0 Td
(has)Tj
1.5363 0 Td
(significant)Tj
4.3824 0 Td
(implications)Tj
5.1647 0 Td
(for)Tj
1.3833 0 Td
(healthcare)Tj
4.3199 0 Td
(payers)Tj
2.778 0 Td
(in)Tj
1.0261 0 Td
(containing)Tj
4.5241 0 Td
(expendi-)Tj
-34.0722 -1.2983 Td
(tures)Tj
2.1996 0 Td
(that)Tj
1.7802 0 Td
(provide)Tj
3.2881 0 Td
(no)Tj
1.2756 0 Td
(or)Tj
1.0999 0 Td
(minimal)Tj
3.6226 0 Td
(benefits)Tj
3.3335 0 Td
(to)Tj
1.0262 0 Td
(patients.)Tj
3.5943 0 Td
(Despite)Tj
3.2485 0 Td
(such)Tj
2.0579 0 Td
(high)Tj
2.0069 0 Td
(expectations,)Tj
5.4142 0 Td
(the)Tj
1.4683 0 Td
(cost-)Tj
-35.4158 -1.3039 Td
(effectiveness)Tj
5.2043 0 Td
(of)Tj
1.0148 0 Td
(cancer)Tj
2.8403 0 Td
(biomarkers)Tj
4.7792 0 Td
(remains)Tj
3.4469 0 Td
(unclear)Tj
3.1918 0 Td
(given)Tj
2.3811 0 Td
(that)Tj
1.7801 0 Td
(they)Tj
1.9219 0 Td
(are)Tj
1.4513 0 Td
(often)Tj
2.2848 0 Td
(co-assessed)Tj
4.7508 0 Td
(as)Tj
-35.0473 -1.2983 Td
(part)Tj
1.8425 0 Td
(of)Tj
1.0148 0 Td
(high)Tj
2.0069 0 Td
(cost)Tj
1.8085 0 Td
(targeted)Tj
3.4639 0 Td
(therapy.)Tj
3.4696 0 Td
(This)Tj
1.9842 0 Td
(study)Tj
2.3924 0 Td
(systematically)Tj
5.743 0 Td
(reviews)Tj
3.2031 0 Td
(economic)Tj
4.1386 0 Td
(evaluations)Tj
4.7225 0 Td
(of)Tj
-35.79 -1.2983 Td
(biomarker-guided)Tj
7.506 0 Td
(therapies)Tj
3.8438 0 Td
(and)Tj
1.7291 0 Td
(aims)Tj
2.1033 0 Td
(to)Tj
1.0262 0 Td
(determine)Tj
4.3199 0 Td
(the)Tj
1.4684 0 Td
(impact)Tj
2.982 0 Td
(of)Tj
1.0148 0 Td
(companion)Tj
4.7905 0 Td
(biomarkers)Tj
4.7792 0 Td
(on)Tj
-35.5632 -1.3039 Td
(the)Tj
1.4683 0 Td
(cost-effectiveness)Tj
7.1432 0 Td
(of)Tj
1.0148 0 Td
(the)Tj
1.4684 0 Td
(corresponding)Tj
6.0604 0 Td
(therapies)Tj
3.8438 0 Td
(in)Tj
1.0374 0 Td
(mCRC.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 401.7259 cm
BT
/F2 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Materials)Tj
4.5071 0 Td
(and)Tj
1.989 0 Td
(methods)Tj
/F10 1 Tf
-6.4961 -1.5023 Td
(Literature)Tj
4.422 0 Td
(search)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 366.6897 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(A)Tj
0.8957 0 Td
(systematic)Tj
4.354 0 Td
(literature)Tj
3.8721 0 Td
(search)Tj
2.7552 0 Td
(on)Tj
1.2643 0 Td
(the)Tj
1.4627 0 Td
(cost-effectiveness)Tj
7.1375 0 Td
(of)Tj
1.0092 0 Td
(cancer)Tj
2.8346 0 Td
(biomarkers)Tj
4.7735 0 Td
(for)Tj
1.3776 0 Td
(targeted)Tj
3.4526 0 Td
(thera-)Tj
-35.189 -1.2982 Td
(pies)Tj
1.7858 0 Td
(in)Tj
1.0374 0 Td
(mCRC)Tj
2.9877 0 Td
(was)Tj
1.7008 0 Td
(performed)Tj
4.4674 0 Td
(using)Tj
2.3924 0 Td
(Medline)Tj
3.549 0 Td
(\(Ovid\),)Tj
3.1181 0 Td
(Embase)Tj
3.3335 0 Td
(\(Ovid\),)Tj
3.1237 0 Td
(EconLit,)Tj
3.6 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
-32.8249 -1.2983 Td
(National)Tj
3.6906 0 Td
(Health)Tj
2.914 0 Td
(Service)Tj
3.0614 0 Td
(Economic)Tj
4.286 0 Td
(Evaluation)Tj
4.507 0 Td
(Database)Tj
3.8495 0 Td
(\(NHSEED\))Tj
4.7508 0 Td
(in)Tj
1.0375 0 Td
(June)Tj
2.0523 0 Td
(2018.)Tj
2.347 0 Td
(The)Tj
1.7802 0 Td
(search)Tj
-34.2763 -1.3039 Td
(terms)Tj
2.4944 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(S2)Tj
1.508 0 Td
(Table)Tj
0 g
(\))Tj
2.7836 0 Td
(were)Tj
2.1204 0 Td
(validated)Tj
3.8324 0 Td
(by)Tj
1.1848 0 Td
(an)Tj
1.2019 0 Td
(information)Tj
5.074 0 Td
(specialist.)Tj
4.0479 0 Td
(The)Tj
1.7801 0 Td
(reference)Tj
3.9175 0 Td
(lists)Tj
1.7518 0 Td
(of)Tj
1.0148 0 Td
(relevant)Tj
-32.7116 -1.2983 Td
(articles)Tj
3.0443 0 Td
(were)Tj
2.1203 0 Td
(scrutinized,)Tj
4.8756 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4684 0 Td
(grey)Tj
1.9388 0 Td
(literature)Tj
3.8778 0 Td
(was)Tj
1.7008 0 Td
(hand-searched.)Tj
-19.5589 -1.2982 Td
(The)Tj
1.7858 0 Td
(electronic)Tj
4.1499 0 Td
(search)Tj
2.7609 0 Td
(was)Tj
1.7008 0 Td
(performed)Tj
4.4674 0 Td
(using)Tj
2.3924 0 Td
(Medical)Tj
3.4355 0 Td
(subject)Tj
3.0161 0 Td
(heading)Tj
3.4129 0 Td
(\(MeSH\))Tj
3.4582 0 Td
(terms)Tj
2.4945 0 Td
(and)Tj
-34.2706 -1.3039 Td
(keywords)Tj
4.0421 0 Td
(that)Tj
1.7802 0 Td
(were)Tj
2.1203 0 Td
(developed)Tj
4.2746 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2756 0 Td
(patients)Tj
3.3675 0 Td
(\(mCRC\),)Tj
3.8948 0 Td
(intervention)Tj
5.176 0 Td
(\(cancer)Tj
3.1861 0 Td
(biomarkers)Tj
4.7792 0 Td
(for)Tj
-36.3682 -1.2983 Td
(targeted)Tj
3.4582 0 Td
(therapies\),)Tj
4.4107 0 Td
(and)Tj
1.7291 0 Td
(outcome)Tj
3.7304 0 Td
(\(ICERs\).)Tj
3.6793 0 Td
(These)Tj
2.5682 0 Td
(were)Tj
2.1203 0 Td
(combined)Tj
4.2463 0 Td
(with)Tj
1.9955 0 Td
(free-word)Tj
4.1669 0 Td
(texts)Tj
2.0637 0 Td
(using)Tj
-34.1686 -1.2983 Td
(relevant)Tj
3.4185 0 Td
(economic)Tj
4.1386 0 Td
(terms)Tj
2.4944 0 Td
(\(e.g.)Tj
1.8992 0 Td
(cost-effectiveness\))Tj
8.2715 0 Td
(and)Tj
1.7291 0 Td
(the)Tj
1.4683 0 Td
(drug)Tj
2.1147 0 Td
(names)Tj
2.8063 0 Td
(of)Tj
1.0148 0 Td
(targeted)Tj
3.4582 0 Td
(therapies)Tj
-32.8136 -1.3039 Td
(both)Tj
2.0579 0 Td
(in)Tj
1.0375 0 Td
(brand)Tj
2.6078 0 Td
(and)Tj
1.7291 0 Td
(generic)Tj
3.1408 0 Td
(terms.)Tj
2.7213 0 Td
(Targeted)Tj
3.7757 0 Td
(therapies)Tj
3.8437 0 Td
(granted)Tj
3.2882 0 Td
(a)Tj
0.652 0 Td
(marketing)Tj
4.3483 0 Td
(authorization)Tj
5.6182 0 Td
(with)Tj
-34.8205 -1.2983 Td
(companion)Tj
4.7905 0 Td
(biomarkers)Tj
4.7792 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
1.474 0 Td
(European)Tj
4.1158 0 Td
(Medicines)Tj
4.354 0 Td
(Agency)Tj
3.2202 0 Td
(\(EMA\))Tj
3.0444 0 Td
(or)Tj
1.0998 0 Td
(US)Tj
1.4343 0 Td
(Food)Tj
2.2904 0 Td
(and)Tj
1.7291 0 Td
(Drug)Tj
-33.5109 -1.2982 Td
(Administration)Tj
6.4175 0 Td
(\(FDA\))Tj
2.8517 0 Td
(were)Tj
2.1203 0 Td
(included)Tj
3.7133 0 Td
(in)Tj
1.0319 0 Td
(the)Tj
1.474 0 Td
(literature)Tj
3.8777 0 Td
(search)Tj
2.761 0 Td
(strategy)Tj
3.3278 0 Td
([)Tj
0.83 0.64 0.02 0 k
(13)Tj
0 g
(].)Tj
2.075 0 Td
(Studies)Tj
3.101 0 Td
(published)Tj
-32.7512 -1.2983 Td
(in)Tj
1.0318 0 Td
(English)Tj
3.2088 0 Td
(were)Tj
2.1203 0 Td
(searched)Tj
3.7133 0 Td
(from)Tj
2.2054 0 Td
(2000)Tj
2.1203 0 Td
(until)Tj
2.1089 0 Td
(June)Tj
2.0523 0 Td
(2018.)Tj
ET
Q
q
1 j
1 J
0 w
11.9999 0 0 11.9999 200.0125 178.0157 cm
BT
/F10 1 Tf
1 TL
-0.0033 Tc
0 0 Td
(Study)Tj
2.6173 0 Td
(selection)Tj
ET
Q
q
1 j
1 J
0 w
10 0 0 10 200.0125 161.0078 cm
BT
/F5 1 Tf
1 TL
-0.004 Tc
0 0 Td
(The)Tj
1.7801 0 Td
(study)Tj
2.3924 0 Td
(selection)Tj
3.7191 0 Td
(was)Tj
1.6951 0 Td
(based)Tj
2.4718 0 Td
(on)Tj
1.2755 0 Td
(the)Tj
1.474 0 Td
(inclusion)Tj
3.9175 0 Td
(and)Tj
1.7291 0 Td
(exclusion)Tj
3.9912 0 Td
(criteria)Tj
3.0727 0 Td
(formulated)Tj
4.6658 0 Td
(by)Tj
1.1792 0 Td
(the)Tj
-33.3635 -1.2982 Td
(PICOS)Tj
3.0047 0 Td
(framework)Tj
4.6147 0 Td
(i.e.,)Tj
1.5874 0 Td
(population,)Tj
4.8132 0 Td
(intervention,)Tj
5.4028 0 Td
(comparator,)Tj
5.1307 0 Td
(outcome,)Tj
3.9515 0 Td
(study)Tj
2.3867 0 Td
(type)Tj
1.9162 0 Td
(\()Tj
0.83 0.64 0.02 0 k
(S3)Tj
1.5081 0 Td
(Table)Tj
0 g
(\).)Tj
-34.316 -1.3039 Td
(Given)Tj
2.6305 0 Td
(the)Tj
1.4683 0 Td
(companion)Tj
4.7905 0 Td
(nature)Tj
2.8233 0 Td
(of)Tj
1.0148 0 Td
(predictive)Tj
4.1953 0 Td
(biomarkers)Tj
4.7792 0 Td
(for)Tj
1.3833 0 Td
(targeted)Tj
3.4639 0 Td
(therapies,)Tj
4.0705 0 Td
(their)Tj
2.109 0 Td
(cost-effec-)Tj
-32.7286 -1.2983 Td
(tiveness)Tj
3.3561 0 Td
(is)Tj
0.8504 0 Td
(interconnected)Tj
6.2532 0 Td
(with)Tj
1.9956 0 Td
(clinical)Tj
3.0784 0 Td
(effectiveness)Tj
5.1987 0 Td
(and)Tj
1.7348 0 Td
(costs)Tj
2.1713 0 Td
(of)Tj
1.0148 0 Td
(corresponding)Tj
6.0548 0 Td
(therapies)Tj
3.8438 0 Td
(as)Tj
-35.5519 -1.2983 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(biomarker)Tj
4.4163 0 Td
(tests.)Tj
2.1884 0 Td
(Hence,)Tj
3.033 0 Td
(the)Tj
1.4683 0 Td
(cost-effectiveness)Tj
7.1433 0 Td
(of)Tj
1.0148 0 Td
(biomarker)Tj
4.4164 0 Td
(testing)Tj
2.8856 0 Td
(as)Tj
1.0148 0 Td
(well)Tj
1.8198 0 Td
(as)Tj
1.0148 0 Td
(corre-)Tj
-33.2501 -1.3039 Td
(sponding)Tj
3.9628 0 Td
(agents)Tj
2.7495 0 Td
(were)Tj
2.1204 0 Td
(included)Tj
3.7133 0 Td
(in)Tj
1.0375 0 Td
(this)Tj
1.6724 0 Td
(review.)Tj
3.0671 0 Td
(Selection)Tj
3.8381 0 Td
(of)Tj
1.0148 0 Td
(papers)Tj
2.8403 0 Td
(followed)Tj
3.651 0 Td
(the)Tj
1.4683 0 Td
(eligibility)Tj
3.9288 0 Td
(crite-)Tj
-35.0643 -1.2982 Td
(ria)Tj
1.2925 0 Td
(below:)Tj
ET
Q
q
1 j
1 J
0 w
576 737.1 m
36 737.1 l
36 737.6 l
576 737.6 l
f*
36 741.2598 107.1496 23.6976 re
W* n
q
107.0929 0 0 23.6409 36 741.3165 cm
q
/I1 Do
Q
Q
Q
q
0 0 612 792 re
W* n
1 j
1 J
0 w
7.9999 0 0 7.9999 311.3574 745.7952 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(Do)Tj
1.474 0 Td
(cancer)Tj
3.1748 0 Td
(biomarke)Tj
4.0394 0 Td
(rs)Tj
1.0417 0 Td
(make)Tj
2.6292 0 Td
(targeted)Tj
3.8268 0 Td
(therap)Tj
2.778 0 Td
(ies)Tj
1.474 0 Td
(cost-effect)Tj
4.5426 0 Td
(ive?)Tj
2.0197 0 Td
(SLR)Tj
2.1401 0 Td
(in)Tj
0.978 0 Td
(mCRC)Tj
ET
Q
q
1 j
1 J
0 w
36 48.0002 m
576 48.0002 l
576 47.5002 l
36 47.5002 l
f*
0.83 0.64 0.02 0 k
81.5811 34.9228 m
237.8835 34.9228 l
h
f*
0 g
7.9999 0 0 7.9999 36 36 cm
BT
/F0 1 Tf
1 TL
-0.005 Tc
0 0 Td
(PLOS)Tj
2.8559 0 Td
(ONE)Tj
2.3669 0 Td
(|)Tj
0.83 0.64 0.02 0 k
0.4748 0 Td
(https://doi.or)Tj
5.4142 0 Td
(g/10.137)Tj
3.8198 0 Td
(1/journal.po)Tj
5.1236 0 Td
(ne.02044)Tj
4.089 0 Td
(96)Tj
0 g
2.0906 0 Td
(September)Tj
5.0386 0 Td
(26,)Tj
1.5874 0 Td
(2018)Tj
32.2798 0 Td
(3)Tj
0.7654 0 Td
(/)Tj
ET
endstream
endobj
63 0 obj
<>stream
endstream
endobj
64 0 obj
<>stream
endstream
endobj
65 0 obj
<>stream
endstream
endobj
66 0 obj
<>stream
endstream
endobj
67 0 obj
<>stream
endstream
endobj
68 0 obj
<>stream
endstream
endobj
69 0 obj
<>stream
endstream
endobj
70 0 obj
<>stream
endstream
endobj
71 0 obj
<>stream
BT
66.402 0 Td
(23)Tj
ET
Q
endstream
endobj
72 0 obj
<>/XObject<>>>/CropBox[0 0 612 792]/MediaBox[0 0 612 792]/Parent 9 0 R/Annots 74 0 R/Contents 75 0 R/TrimBox[0 0 612 792]>>
endobj
73 0 obj
<>
endobj
76 0 obj
<>
endobj
77 0 obj
<>stream
%!PS-AdobeFont-1.0
11 dict begin
/FontName /PI_chars_3 def
/FontType 1 def
/FontBBox {-11 -345 1373 718} readonly def
/FontMatrix [0.001 0 0 0.001 0 0] readonly def
/PaintType 0 def
/FontInfo 8 dict dup begin
/FullName (PI_chars_3) readonly def
/BaseFontName (PI_chars_3) def
end def
/Encoding 256 array
0 1 255 {1 index exch /.notdef put} for
dup 33 /exclam put
dup 34 /quotedbl put
dup 35 /numbersign put
dup 36 /dollar put
dup 37 /percent put
dup 38 /ampersand put
dup 39 /quoteright put
dup 40 /parenleft put
dup 41 /parenright put
dup 42 /asterisk put
dup 43 /plus put
dup 44 /comma put
dup 45 /hyphen put
dup 46 /period put
dup 47 /slash put
dup 49 /one put
dup 50 /two put
dup 51 /three put
dup 52 /four put
dup 53 /five put
dup 54 /six put
dup 55 /seven put
dup 56 /eight put
dup 58 /colon put
dup 60 /less put
dup 61 /equal put
dup 62 /greater put
dup 63 /question put
dup 64 /at put
dup 65 /A put
dup 66 /B put
dup 67 /C put
dup 68 /D put
dup 69 /E put
dup 70 /F put
dup 71 /G put
dup 72 /H put
dup 73 /I put
dup 74 /J put
dup 75 /K put
dup 76 /L put
dup 77 /M put
dup 78 /N put
dup 79 /O put
dup 80 /P put
dup 81 /Q put
dup 82 /R put
dup 83 /S put
dup 84 /T put
dup 85 /U put
dup 86 /V put
dup 87 /W put
dup 88 /X put
dup 89 /Y put
dup 90 /Z put
dup 91 /bracketleft put
dup 92 /backslash put
dup 93 /bracketright put
dup 94 /asciicircum put
dup 97 /a put
dup 98 /b put
dup 99 /c put
dup 100 /d put
dup 101 /e put
dup 102 /f put
dup 103 /g put
dup 104 /h put
dup 105 /i put
dup 106 /j put
dup 107 /k put
dup 108 /l put
dup 109 /m put
dup 110 /n put
dup 111 /o put
dup 112 /p put
dup 113 /q put
dup 114 /r put
dup 115 /s put
dup 116 /t put
dup 117 /u put
dup 118 /v put
dup 119 /w put
dup 120 /x put
dup 121 /y put
dup 122 /z put
dup 123 /braceleft put
dup 124 /bar put
dup 125 /braceright put
dup 126 /asciitilde put
readonly def
currentdict end
currentfile eexec
M#1H5 J6o\&rtS(#v\0\V7Fe༙OYx5-cY9^%Y6
(efIOldN"wȰ;)UƽoFg/rvV$JS8_oc@
o9-eGJp}[Do]mN=4*{ܯq=eU^t6¤/{zM4aܪ
Q:д'B-r^ܦ6y?rRnu S\U{Oλrs(Βƚ
#d29%s'ƈT1F8&\0Xd&&Zug'VPd]:>u=Q,?#(CV4'..|ӱ5 h
sȀg)fɘ`UXK^>] q\l#5pE"JO}rquáQBr/E7
QW5\GSlu{7ZH(PSf/O;̟w{ɴ}-K hA8!b!U>`#u?Vlnǝ19V+mg'QmA}S Y$í8n uJ ڒx3>[x0Z]
ͩw4M&1+pkC,sr"%q&OjbH{:5$65*S`cr;%s4Oӆe>T+6~pBOD!$c]"~r#nh6$38i˞[~Z}}rHmte9(1½=j{<\ ;? RA?c{Rf1'VԞ_-Lwo]`.l|zjf"![G1BYro˓9[-+z g!}RN+pX!M~HcFh@g%J6B)6!Lq>TX\ݪGF
PiQݓX~Fs;Ölo4/(C?+,ɖxۼ:xU^)
fd,`*>-:}=q$:\Xzcw1Nf(
ZkEeJXfэi@zXc\{a5qKg\5ݩv\Qe%1>OY̗$Y#P[)."^+{"bP]Bt&zeN6
іijDE% 0;̅
~~lfB>u'i4znym%tfԟ^נBTDS6-ghiWk/(r!!˶fc>趕%U